SCHEMBL31078058

SCHEMBL31078058

O=C(Nc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1)c1cccc(-c2ccccc2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 2/20 0.62
▸ NR1H4 Q96RI1 1/20 0.59
▸ NPC1 O15118 2/20 0.58
▸ RAB9A P51151 2/20 0.58
▸ LMNA P02545 2/20 0.57
▸ PTPN1 P18031 2/20 0.56
▸ RXFP1 Q9HBX9 1/20 0.55
▸ KCNK3 O14649 1/20 0.54
▸ MAPK1 P28482 2/20 0.54
▸ PTGS1 P23219 1/20 0.53
▸ MEN1 O00255 1/20 0.53
▸ POLB P06746 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ XBP1 P17861 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ P2RX1 P51575 1/20 0.52
▸ UGCG Q16739 1/20 0.52
▸ SIRT1 Q96EB6 2/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31078052 0.89 RORC (0.73) RORCNR1H4NPC1RAB9APTPN1
SCHEMBL5314168 0.89 RORC (0.77) RORCNPC1RAB9APTPN1MAPK1
SCHEMBL31078087 0.84 RORC (0.65) RORCNPC1RAB9ALMNAKCNK3
SCHEMBL31078143 0.84 RORC (0.74) RORCNPC1RAB9ALMNARXFP1
SCHEMBL27760395 0.83 PTPN1 (0.76) NR1H4NPC1RAB9APTPN1MEN1
SCHEMBL31077922 0.83 RAB9A (0.63) RORCNPC1RAB9ALMNARXFP1
SCHEMBL31078038 0.83 RORC (0.63) RORCNPC1RAB9ALMNAKCNK3
SCHEMBL2025738 0.81 NR1H4 (0.72) NR1H4NPC1RAB9ALMNAPTPN1
SCHEMBL8745242 0.80 PTPN1 (0.77) NR1H4NPC1RAB9APTPN1KCNK3
SCHEMBL12424027 0.80 PTPN1 (0.82) NR1H4NPC1RAB9APTPN1KCNK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240245633-A1 ROR Gamma Agonists as Enhancers of Protective Immunity UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2024-07-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240245633-A1 ROR Gamma Agonists as Enhancers of Protective Immunity RORC, RORB, RORA RORC 1/4885NR1H4 537/4885NPC1 4231/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback